October 2, 2012 — AstraZeneca has announced the results from a sub-analysis of PLATO that evaluated the effects of age ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
October 02, 2012
October 2, 2012 — A novel blood thinner recently approved by the U.S. Food and Drug Administration (FDA), Pradaxa ...
October 02, 2012
October 1, 2012 — Bristol-Myers Squibb Company and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA ...
October 01, 2012September 28, 2012 — Accumetrics Inc., developer of the VerifyNow System, the first rapid and easy-to-use point-of-care ...
September 28, 2012
September 25, 2012 — Men and women who undergo joint replacement procedures, as well as those who have significant ...
September 25, 2012
September 17, 2012 — The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report ...
September 17, 2012September 13, 2012 — Janssen Research & Development LLC announced that it has submitted the complete response to the U.S ...
September 13, 2012
September 7, 2012 — St. Jude Medical Inc. announced results of the FAME II trial demonstrating that patients with fracti ...
September 07, 2012September 6, 2012 — Daiichi Sankyo Co. Ltd. and Eli Lilly and Co. announced data from the TRILOGY ACS study, a phase III ...
September 06, 2012August 30, 2012 — Aspirin combined with the antiplatelet drug clopidogrel is no better than aspirin alone for stroke ...
August 30, 2012
August 30, 2012 — Baseline data from the first cohort of the Global Anticoagulant Registry in the Field (GARFIELD), an ...
August 30, 2012
Feature | Nicole Fornell, Pharm D
A major issue with clopidogrel is that one-third of patients are nonresponders because they lack the enzymes to ...
August 28, 2012
Feature | Antiplatelet and Anticoagulation Therapies | Nicole Fornell, Pharm D
The standard-of-care for dual antiplatelet therapy (DAPT) for more than a decade has been clopidogrel (Plavix) plus ...
August 28, 2012August 23, 2012 — Decision Resources, a research and advisory firm for pharmaceutical and healthcare issues, finds that ...
August 23, 2012
August 9, 2012 — The Harvard Clinical Research Institute (HCRI) announced today the successful completion of ...
August 09, 2012© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now